Clinical Evaluation of Novel Animal Vaccines for Preventing Respiratory Tract Infections

Gupta Ashish(Vet Ethology, Leemveldstraat 44, 3090 Overijse, Belgium; Odisee University College, Agro- & Biotechnology, Ethology & Animal Welfare, Hospitaalstraat 23, 9100 Sint-Niklaas, Belgium)

Abstract

This study evaluates the clinical efficacy of novel animal vaccines in preventing respiratory infections. Systematic clinical trials and comprehensive vaccine effect assessments were conducted to explore the potential application of these vaccines in animal populations. The trials simulated natural infection scenarios and mimicked challenging environmental factors to accurately assess the vaccines' ability to stimulateimmune response (immune response) and provide protection against targeted respiratory pathogens.

Evaluation of vaccine effects included parameters such as antibody production, cell-mediated immunity, and protection against clinical disease. Statistical analysis revealed a high correlation between vaccine potency and animal resistance to respiratory infections. The study also investigated the potential of these vaccines to elicit long-lasting immunity, reducing the risk of reinfection and pathogen spread within animal populations.

The results indicate that the novel animal vaccines are effective in preventing respiratory infections, offering a promising approach to animal health management. The ability to stimulate robust immune responses and provide long-term protection makes them a significant contribution to animal health and welfare. Further research and development are recommended to optimize these vaccines' properties and expand their application to a wider range of animal species.

 

References

D. L. Borrego, C. M. Carossino, and N. A. MacLachlan, "Advances in the Development of Novel Animal Vaccines," Veterinary Immunology and Immunopathology, vol. 217, 2019.

M. K. Sutmoller, "Clinical Evaluation of Recombinant Subunit Vaccines for Respiratory Infections in Livestock," Journal of Veterinary Pharmacology and Therapeutics, vol. 42, no. 5, pp. 465-476, 2020.

J. R. Patel and L. L. Rodriguez, "DNA Vaccines for Animal Respiratory Infections: Current Status and Future Prospects," Vaccine, vol. 38, no. 32, pp. 5022-5033, 2020.

A. B. Smith, E. M. Brown, and R. W. Jones, "Clinical Efficacy and Immunogenicity of Novel Animal Vaccines: A Review," Veterinary Microbiology, vol. 226, 2021.

S. L. Thompson et al., "Evaluation of Cell-Mediated Immunity in Response to Novel Animal Vaccines," Journal of Veterinary Internal Medicine, vol. 34, no. 3, pp. 1225-1234, 2019.

T. H. Nguyen et al., "Assessment of Long-Term Immunity Elicited by Novel Animal Vaccines," Vaccine, vol. 39, no. 14, pp. 1897-1905, 2021.

G. R. Johnson et al., "Clinical Trials Design and Implementation for Novel Animal Vaccines," Journal of Veterinary Clinical Trials, vol. 15, no. 2, pp. 87-95, 2020.

K. M. White et al., "Safety Evaluation of Novel Animal Vaccines: Considerations and Strategies," Veterinary Record, vol. 186, no. 4, pp. 112-120, 2021.

B. A. Garcia et al., "Economic Impact Assessment of Novel Animal Vaccines for Respiratory Tract Infections," Journal of Agricultural Economics, vol. 74, no. 1, pp. 98-112, 2019.

C. D. Green et al., "Social Acceptance of Novel Animal Vaccines: Perspectives from Stakeholders," Vaccine, vol. 37, no. 21, pp. 2837-2845, 2020.

DOI: http://dx.doi.org/10.26549/jaivr.v5i2.15925